JP2023524684A5 - - Google Patents
Info
- Publication number
- JP2023524684A5 JP2023524684A5 JP2022566065A JP2022566065A JP2023524684A5 JP 2023524684 A5 JP2023524684 A5 JP 2023524684A5 JP 2022566065 A JP2022566065 A JP 2022566065A JP 2022566065 A JP2022566065 A JP 2022566065A JP 2023524684 A5 JP2023524684 A5 JP 2023524684A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- pharmaceutically acceptable
- compound
- acceptable salt
- pi3kα
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024073451A JP2024099776A (ja) | 2020-04-29 | 2024-04-30 | PI3Kα阻害剤およびそれらの使用 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063017571P | 2020-04-29 | 2020-04-29 | |
| US63/017,571 | 2020-04-29 | ||
| US202063066489P | 2020-08-17 | 2020-08-17 | |
| US63/066,489 | 2020-08-17 | ||
| PCT/US2021/029882 WO2021222556A1 (en) | 2020-04-29 | 2021-04-29 | PI3K-α INHIBITORS AND METHODS OF USE THEREOF |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024073451A Division JP2024099776A (ja) | 2020-04-29 | 2024-04-30 | PI3Kα阻害剤およびそれらの使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023524684A JP2023524684A (ja) | 2023-06-13 |
| JP2023524684A5 true JP2023524684A5 (cg-RX-API-DMAC10.html) | 2024-05-13 |
| JP7508584B2 JP7508584B2 (ja) | 2024-07-01 |
Family
ID=78373965
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022566065A Active JP7508584B2 (ja) | 2020-04-29 | 2021-04-29 | PI3Kα阻害剤およびそれらの使用 |
| JP2024073451A Pending JP2024099776A (ja) | 2020-04-29 | 2024-04-30 | PI3Kα阻害剤およびそれらの使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024073451A Pending JP2024099776A (ja) | 2020-04-29 | 2024-04-30 | PI3Kα阻害剤およびそれらの使用 |
Country Status (14)
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2021263914B2 (en) * | 2020-04-29 | 2026-07-23 | D.E. Shaw Research, Llc | PI3K-α inhibitors and methods of use thereof |
| WO2022213062A1 (en) | 2021-03-29 | 2022-10-06 | Nimbus Saturn, Inc. | Hpk1 antagonists and uses thereof |
| TW202334136A (zh) * | 2021-11-03 | 2023-09-01 | 美商傳達治療有限公司 | PI3Kα抑制劑及其製造與使用方法 |
| WO2023098880A1 (zh) * | 2021-12-02 | 2023-06-08 | 上海翰森生物医药科技有限公司 | 稠环类衍生物调节剂、其制备方法和应用 |
| WO2023114973A1 (en) | 2021-12-17 | 2023-06-22 | Shure Acquisition Holdings, Inc. | Adaptive acoustic echo cancellation for a stereo audio signal |
| TW202333670A (zh) * | 2022-01-04 | 2023-09-01 | 大陸商海思科醫藥集團股份有限公司 | 抑制並降解irak4的化合物及其藥物组合物和藥學上的應用 |
| US20250313524A1 (en) * | 2022-05-10 | 2025-10-09 | Relay Therapeutics, Inc. | Pi3k-alpha inhibitors and methods of use thereof |
| CN116655602B (zh) * | 2022-07-12 | 2025-09-16 | 苏州浦合医药科技有限公司 | PI3Kα变构抑制剂 |
| IL318203A (en) * | 2022-07-12 | 2025-03-01 | Adama Makhteshim Ltd | Process for preparing modified benzamides |
| CN120152713A (zh) * | 2022-07-29 | 2025-06-13 | 昂胜医疗科技公司 | 三环芳基衍生物及其组合物和方法 |
| CA3262681A1 (en) * | 2022-07-29 | 2024-02-01 | Ensem Therapeutics, Inc. | TRICYCLIC ARYL DERIVATIVES, AND ASSOCIATED COMPOSITIONS AND PROCESSES |
| WO2024030863A1 (en) | 2022-08-05 | 2024-02-08 | Scorpion Therapeutics, Inc. | Pi3k-alpha inhibitors for the treatment of cancer |
| US20260041669A1 (en) | 2022-08-11 | 2026-02-12 | Relay Therapeutics, Inc. | Solid forms of a cdk inhibitor |
| EP4585596A4 (en) * | 2022-09-09 | 2025-12-10 | Shanghai Yingli Pharm Co Ltd | Nitrogen-containing heterocyclic compound, pharmaceutical composition thereof and uses thereof |
| WO2024055992A1 (zh) * | 2022-09-14 | 2024-03-21 | 南京再明医药有限公司 | 三环化合物及其应用 |
| JP2025538147A (ja) * | 2022-11-02 | 2025-11-26 | ペトラ・ファーマ・コーポレイション | 疾患の治療のためのホスホイノシチド3-キナーゼ(pi3k)のアロステリックポケット及びオルソステリックポケットの標的化 |
| JP2025163068A (ja) * | 2022-11-02 | 2025-10-28 | ペトラ・ファーマ・コーポレイション | 疾患の治療のためのホスホイノシチド3-キナーゼ(pi3k)のアロステリックポケット及びオルソステリックポケットの標的化 |
| WO2024094163A1 (zh) * | 2022-11-03 | 2024-05-10 | 上海翰森生物医药科技有限公司 | 多环并环衍生物、其制备方法和应用 |
| CN120676939A (zh) * | 2023-01-13 | 2025-09-19 | 传达治疗有限公司 | Pi3k抑制剂及其制备和使用方法 |
| WO2024153238A1 (zh) * | 2023-01-20 | 2024-07-25 | 南京再明医药有限公司 | 四环化合物及其应用 |
| WO2024233256A1 (en) | 2023-05-05 | 2024-11-14 | Eli Lilly And Company | Imlunestrant or salts thereof for use in treating and preventing central nervous system (cns) metastases in subjects having er+ breast cancer |
| WO2025165834A1 (en) * | 2024-01-31 | 2025-08-07 | Ensem Therapeutics, Inc. | Urea derivatives of tricyclic compounds, and compositions and methods thereof |
| WO2025179441A1 (zh) * | 2024-02-27 | 2025-09-04 | 上海璎黎药业有限公司 | 一种三并环结构化合物、其药物组合物及应用 |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1743997A (en) | 1996-12-20 | 1998-07-17 | Geron Corporation | Poly(adp-ribose) polymerase inhibitors to treat diseases associated with cellular senescence |
| CA2528938A1 (en) | 2003-06-13 | 2005-02-24 | Zentaris Gmbh | Compounds having inhibitive activity of phosphatidylinositol 3-kinase and methods of use thereof |
| HRP20130902T1 (hr) | 2005-10-07 | 2013-11-08 | Exelixis Inc. | PIRIDOPIRIMIDINONSKI INHIBITORI PI3Kalfa |
| ZA200904857B (en) | 2007-02-22 | 2010-09-29 | Merck Serono Sa | Quinoxaline compounds and use thereof |
| WO2009071895A1 (en) | 2007-12-04 | 2009-06-11 | Ucb Pharma S.A. | Fused thiazole and thiophene derivatives as kinase inhibitors |
| UA111579C2 (uk) * | 2009-08-17 | 2016-05-25 | Інтеллікіне Ллк | ГЕТЕРОЦИКЛІЧНІ ПОХІДНІ 2-АМІНОБЕНЗО[d]ОКСАЗОЛУ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ НА ЇХ ОСНОВІ ТА ЇХ ЗАСТОСУВАННЯ ДЛЯ ЛІКУВАННЯ ЗАХВОРЮВАННЯ, ПОВ'АНОГО З РІ3-КІНАЗОЮ |
| WO2011067365A1 (en) | 2009-12-03 | 2011-06-09 | Glaxo Group Limited | Benzpyrazole derivatives as inhibitors of p13 kinases |
| RU2573569C2 (ru) * | 2009-12-22 | 2016-01-20 | Вертекс Фармасьютикалз Инкорпорейтед | Ингибиторы фосфатидилинозитол-3-киназы на основе изоиндолинона |
| WO2011114148A1 (en) | 2010-03-17 | 2011-09-22 | Astrazeneca Ab | 4h- [1, 2, 4] triazolo [5, 1 -b] pyrimidin-7 -one derivatives as ccr2b receptor antagonists |
| JP2013544827A (ja) | 2010-11-24 | 2013-12-19 | エクセリクシス, インク. | PI3K/mTORの阻害剤としてのベンゾオキサゼピン類ならびにそれらの使用法および製造法 |
| CN102140087B (zh) | 2011-01-27 | 2013-02-13 | 清华大学 | 一种色酮类化合物的合成方法 |
| US8846656B2 (en) * | 2011-07-22 | 2014-09-30 | Novartis Ag | Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as C5a receptor modulators |
| TWI574962B (zh) | 2012-11-14 | 2017-03-21 | 加拓科學公司 | 作爲pi3激酶調節劑的芳雜環化合物及其使用方法和用途 |
| TR201904614T4 (en) * | 2013-02-27 | 2019-05-21 | Mochida Pharm Co Ltd | Novel pyrazole derivative. |
| JO3368B1 (ar) | 2013-06-04 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2 |
| JP6472803B2 (ja) | 2013-09-05 | 2019-02-20 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | トリアゾロピリジン化合物、その組成物及び使用方法 |
| WO2017000277A1 (en) | 2015-07-01 | 2017-01-05 | Merck Sharp & Dohme Corp. | Substituted triazolo bicycliccompounds as pde2 inhibitors |
| CA2990521C (en) | 2015-07-07 | 2023-10-10 | H. Lundbeck A/S | Pde9 inhibitors with imidazo triazinone backbone and imidazo pyrazinone backbone for treatment of peripheral diseases |
| GB201517217D0 (en) | 2015-09-29 | 2015-11-11 | Astex Therapeutics Ltd And Cancer Res Technology Ltd | Pharmaceutical compounds |
| EP3400218A4 (en) | 2016-01-08 | 2019-09-18 | Euclises Pharmaceuticals, Inc. | COMBINATION OF A CHROME CONNECTION AND A SECOND ACTIVE SUBSTANCE |
| PL3478679T3 (pl) * | 2016-07-01 | 2021-10-25 | Pfizer Inc. | Pochodne 5,7-dihydro-pirolopirydyny do leczenia chorób neurologicznych i neurodegeneracyjnych |
| EP3596075B1 (en) * | 2017-03-15 | 2023-10-11 | F. Hoffmann-La Roche AG | Azaindoles as inhibitors of hpk1 |
| CN109265443B (zh) * | 2017-07-18 | 2022-11-29 | 南京圣和药业股份有限公司 | 作为ask抑制剂的杂环化合物及其应用 |
| MY201041A (en) | 2017-11-24 | 2024-01-31 | Sumitomo Pharma Co Ltd | Substituted pyrazolo[1,5-a]pyrazines as negative allosteric modulators of group ii metabotropic glutamate receptor |
| RS65576B1 (sr) | 2017-11-24 | 2024-06-28 | Jubilant Episcribe Llc | Heterociklična jedinjenja kao inhibitori prmt5 |
| US11512054B2 (en) | 2017-12-21 | 2022-11-29 | Basf Se | Pesticidal compounds |
| GB201801355D0 (en) | 2018-01-26 | 2018-03-14 | Enterprise Therapeutics Ltd | Compounds |
| US12138263B2 (en) | 2018-03-21 | 2024-11-12 | Relay Therapeutics, Inc. | Pyrazolo[3,4-b]pyrazine SHP2 phosphatase inhibitors and methods of use thereof |
| EP3931188B1 (en) | 2019-02-26 | 2023-08-30 | Boehringer Ingelheim International GmbH | New isoindolinone substituted indoles and derivatives as ras inhibitors |
| GB201905328D0 (en) | 2019-04-15 | 2019-05-29 | Azeria Therapeutics Ltd | Inhibitor compounds |
| ES3065954T3 (en) | 2019-05-13 | 2026-05-08 | Relay Therapeutics Inc | Fgfr inhibitors and methods of use thereof |
| US12409171B2 (en) | 2019-06-20 | 2025-09-09 | University Of Kentucky Research Foundation | Pharmaceutically active pyrazolo-pyridone modulators of DCN1/2-mediated cullin neddylation |
| AU2021263914B2 (en) | 2020-04-29 | 2026-07-23 | D.E. Shaw Research, Llc | PI3K-α inhibitors and methods of use thereof |
| US11667636B2 (en) | 2020-12-24 | 2023-06-06 | Escient Pharmaceuticals, Inc. | Modulators of Mas-related G-protein receptor X2 and related products and methods |
| AR126447A1 (es) | 2021-07-13 | 2023-10-11 | Relay Therapeutics Inc | INHIBIDORES DE PI3Ka Y MÉTODOS DE USO DE LOS MISMOS |
| EP4399196A4 (en) | 2021-09-10 | 2025-08-06 | Relay Therapeutics Inc | PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF |
| EP4412606A4 (en) | 2021-10-07 | 2025-09-24 | Relay Therapeutics Inc | PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF |
| TW202334136A (zh) | 2021-11-03 | 2023-09-01 | 美商傳達治療有限公司 | PI3Kα抑制劑及其製造與使用方法 |
| US20260131009A1 (en) | 2021-11-03 | 2026-05-14 | Relay Therapeutics, Inc. | Bifunctional pi3k-alpha inhibitors and uses thereof |
| US20250313524A1 (en) | 2022-05-10 | 2025-10-09 | Relay Therapeutics, Inc. | Pi3k-alpha inhibitors and methods of use thereof |
| CN120676939A (zh) | 2023-01-13 | 2025-09-19 | 传达治疗有限公司 | Pi3k抑制剂及其制备和使用方法 |
| KR20260113070A (ko) | 2023-11-15 | 2026-07-21 | 릴레이 테라퓨틱스, 인크. | PI3Kα 저해제 그리고 이의 제조 방법 및 사용 방법 |
-
2021
- 2021-04-29 AU AU2021263914A patent/AU2021263914B2/en active Active
- 2021-04-29 CN CN202610338644.4A patent/CN122277553A/zh active Pending
- 2021-04-29 PE PE2022002518A patent/PE20231073A1/es unknown
- 2021-04-29 IL IL325094A patent/IL325094A/en unknown
- 2021-04-29 WO PCT/US2021/029882 patent/WO2021222556A1/en not_active Ceased
- 2021-04-29 KR KR1020257012192A patent/KR20250057919A/ko active Pending
- 2021-04-29 JP JP2022566065A patent/JP7508584B2/ja active Active
- 2021-04-29 CN CN202510407046.3A patent/CN120247911B/zh active Active
- 2021-04-29 KR KR1020227041794A patent/KR102797536B1/ko active Active
- 2021-04-29 EP EP21795690.3A patent/EP4143196A4/en active Pending
- 2021-04-29 PH PH1/2022/500017A patent/PH12022500017A1/en unknown
- 2021-04-29 IL IL297625A patent/IL297625B2/en unknown
- 2021-04-29 BR BR112022021854A patent/BR112022021854A2/pt unknown
- 2021-04-29 CA CA3174675A patent/CA3174675A1/en active Pending
- 2021-04-29 MX MX2022013417A patent/MX2022013417A/es unknown
- 2021-04-29 CN CN202180043509.2A patent/CN116261562A/zh active Pending
- 2021-04-29 US US17/921,580 patent/US12581252B2/en active Active
-
2022
- 2022-10-27 CL CL2022002985A patent/CL2022002985A1/es unknown
-
2023
- 2023-06-09 US US18/208,023 patent/US12219327B2/en active Active
- 2023-11-30 CL CL2023003583A patent/CL2023003583A1/es unknown
-
2024
- 2024-04-30 JP JP2024073451A patent/JP2024099776A/ja active Pending
-
2025
- 2025-12-11 US US19/416,280 patent/US20260205746A1/en active Pending